Skip to main content

Table 4 Factors that are correlated with 3 month FMD values of the cilostazol group in multiple linear regression analysis

From: Cilostazol improves endothelial function in acute cerebral ischemia patients: a double-blind placebo controlled trial with flow-mediated dilation technique

 

Univariate analysis

 

Multivariate analysis (r2 = 0.695)

 

Factors

r

p

ß

SE

95% CI

p

Age

–.286

0.113

–0.036

0.024

(–0.086, 0.013)

0.145

Initial mean BP

.003

0.988

    

3 month mean BP

–.007

0.968

    

Hemoglobin

.003

0.988

    

Glucose

.122

0.507

    

Total cholesterol

.249

0.170

0.009

0.008

(–0.008, 0.025)

0.290

Triglyceride

.162

0.376

    

HDL

.017

0.927

    

LDL

.219

0.228

    

ESR

–.004

0.982

    

CRP

–.352

0.048

–3.267

0.984

(−5.285, –1.248)

0.003

L-arginine

–.508

0.003

–0.050

0.012

(−0.075, –0.024)

<0.001

  1. FMD flow mediated dilation; BP blood pressure; HDL high density lipoprotein; LDL low density lipoprotein; ESR erythrocyte sedimentation rate; CRP c-reactive protein
Back to article page

BMC Neurology

ISSN: 1471-2377

Contact us